Susquehanna International Group, LLP Pro Qr Therapeutics N.V. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 42,223 shares of PRQR stock, worth $117,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,223

Previous 96,118 56.07%

Holding current value

$117,802

Previous $159,000 52.2%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.64 - $2.24 $88,387 - $120,724	-53,895 Reduced 56.07%	42,223 $76,000
Q2 2024 Aug 15, 2024	SELL	$1.65 - $2.39 $72,654 - $105,238	-44,033 Reduced 31.42%	96,118 $159,000
Q1 2024 May 07, 2024	BUY	$1.89 - $2.85 $238,487 - $359,624	126,184 Added 903.44%	140,151 $320,000
Q4 2023 Feb 14, 2024	SELL	$1.15 - $2.21 $30,639 - $58,881	-26,643 Reduced 65.61%	13,967 $27,000
Q3 2023 Nov 14, 2023	BUY	$1.3 - $1.77 $52,793 - $71,879	40,610 New	40,610 $52,000
Q4 2022 Feb 14, 2023	BUY	$0.8 - $3.7 $131,856 - $609,837	164,821 New	164,821 $609,000
Q2 2022 Aug 15, 2022	BUY	$0.56 - $1.0 $535 - $956	956 Added 2.48%	39,565 $31,000
Q4 2021 Feb 14, 2022	SELL	$6.58 - $8.44 $589,943 - $756,705	-89,657 Reduced 69.9%	38,609 $309,000
Q3 2021 Nov 15, 2021	BUY	$5.16 - $8.47 $440,700 - $723,397	85,407 Added 199.27%	128,266 $1.07 Million
Q2 2021 Aug 11, 2021	SELL	$5.75 - $7.59 $123,044 - $162,418	-21,399 Reduced 33.3%	42,859 $289,000
Q1 2021 May 17, 2021	BUY	$4.14 - $9.22 $266,028 - $592,458	64,258 New	64,258 $425,000
Q3 2020 Nov 16, 2020	SELL	$4.79 - $6.3 $55,089 - $72,456	-11,501 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.5 - $6.53 $5,656 - $8,208	-1,257 Reduced 9.85%	11,501 $70,000
Q1 2020 May 15, 2020	SELL	$5.25 - $9.9 $20,947 - $39,501	-3,990 Reduced 23.82%	12,758 $70,000
Q4 2019 Feb 14, 2020	BUY	$5.84 - $10.51 $97,808 - $176,021	16,748 New	16,748 $166,000
Q2 2018 Aug 14, 2018	SELL	$2.95 - $7.45 $46,919 - $118,492	-15,905 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.9 - $3.5 $40,542 - $48,930	-13,980 Reduced 46.78%	15,905 $49,000
Q4 2017 Feb 14, 2018	BUY	$2.8 - $4.8 $83,678 - $143,448	29,885	29,885 $96,000

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.4M

Call Options Held

37.7K

Put Options Held

21.3K

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $199M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Pro Qr Therapeutics N.V. Transaction History